The recently identified hexosaminidase D enzyme substantially contributes to the elevated hexosaminidase activity in rheumatoid arthritis

Mária Pásztói, Barbara Sódar, Petra Misják, Krisztina Pálóczi, A. Kittel, Kálmán Tóth, Károly Wellinger, P. Géher, György Nagy, Tamás Lakatos, A. Falus, E. Búzás

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Since the 1970s, numerous reports have described elevated hexosaminidase activities in rheumatoid arthritis. However, due to the overlapping substrate specificities of different hexosaminidases, identification of the exact enzyme(s) responsible for the elevated activity remains incomplete.In this work we tested if the recently described enzyme, hexosaminidase D was expressed in human arthritic joints, and could contribute to the elevated hexosaminidase activity in rheumatoid arthritis.Thermostable β-d-N-acetyl-galactosaminidase (hexosaminidase D) activities were determined in synovial fluid samples, synovial membranes, synovial fibroblast cell strains and synovial fibroblast-derived extracellular vesicles of patients with rheumatoid arthritis and osteoarthritis using chromogenic substrates. Expression of the HEXDC gene was detected both in steady state and in TGF-β treated synovial fibroblasts by real time PCR.Strikingly, hexosaminidase D accounted for approximately 50% of the total β-N-acetyl-galactosaminidase activity in synovial membranes and synovial fibroblasts, and it was responsible for the vast majority of the β-d-N-acetyl-galactosaminidase activity in synovial fluid samples. TGF-β downregulated the expression of hexosaminidase D in synovial fibroblasts dose-dependently. Of note, significant activity of hexosaminidase D was also found in association with extracellular vesicles released by synovial fibroblasts.This first study that describes the expression and disease relevance of the HEXDC gene in humans demonstrates the expression of this novel enzyme within the joints, and suggests that its activity may significantly contribute to the overall local exoglycosidase activity.

Original languageEnglish
Pages (from-to)71-76
Number of pages6
JournalImmunology Letters
Volume149
Issue number1-2
DOIs
Publication statusPublished - Jan 2013

Fingerprint

4 alpha-glucanotransferase
Hexosaminidases
Rheumatoid Arthritis
Fibroblasts
Synovial Membrane
Synovial Fluid
Joints
Chromogenic Compounds
Glycoside Hydrolases

Keywords

  • Extracellular vesicle
  • Hexosaminidase
  • Rheumatoid arthritis
  • Synovial fibroblast
  • Transforming growth factor beta

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

The recently identified hexosaminidase D enzyme substantially contributes to the elevated hexosaminidase activity in rheumatoid arthritis. / Pásztói, Mária; Sódar, Barbara; Misják, Petra; Pálóczi, Krisztina; Kittel, A.; Tóth, Kálmán; Wellinger, Károly; Géher, P.; Nagy, György; Lakatos, Tamás; Falus, A.; Búzás, E.

In: Immunology Letters, Vol. 149, No. 1-2, 01.2013, p. 71-76.

Research output: Contribution to journalArticle

Pásztói, Mária ; Sódar, Barbara ; Misják, Petra ; Pálóczi, Krisztina ; Kittel, A. ; Tóth, Kálmán ; Wellinger, Károly ; Géher, P. ; Nagy, György ; Lakatos, Tamás ; Falus, A. ; Búzás, E. / The recently identified hexosaminidase D enzyme substantially contributes to the elevated hexosaminidase activity in rheumatoid arthritis. In: Immunology Letters. 2013 ; Vol. 149, No. 1-2. pp. 71-76.
@article{a067872a923844bea1b758c5b35abb33,
title = "The recently identified hexosaminidase D enzyme substantially contributes to the elevated hexosaminidase activity in rheumatoid arthritis",
abstract = "Since the 1970s, numerous reports have described elevated hexosaminidase activities in rheumatoid arthritis. However, due to the overlapping substrate specificities of different hexosaminidases, identification of the exact enzyme(s) responsible for the elevated activity remains incomplete.In this work we tested if the recently described enzyme, hexosaminidase D was expressed in human arthritic joints, and could contribute to the elevated hexosaminidase activity in rheumatoid arthritis.Thermostable β-d-N-acetyl-galactosaminidase (hexosaminidase D) activities were determined in synovial fluid samples, synovial membranes, synovial fibroblast cell strains and synovial fibroblast-derived extracellular vesicles of patients with rheumatoid arthritis and osteoarthritis using chromogenic substrates. Expression of the HEXDC gene was detected both in steady state and in TGF-β treated synovial fibroblasts by real time PCR.Strikingly, hexosaminidase D accounted for approximately 50{\%} of the total β-N-acetyl-galactosaminidase activity in synovial membranes and synovial fibroblasts, and it was responsible for the vast majority of the β-d-N-acetyl-galactosaminidase activity in synovial fluid samples. TGF-β downregulated the expression of hexosaminidase D in synovial fibroblasts dose-dependently. Of note, significant activity of hexosaminidase D was also found in association with extracellular vesicles released by synovial fibroblasts.This first study that describes the expression and disease relevance of the HEXDC gene in humans demonstrates the expression of this novel enzyme within the joints, and suggests that its activity may significantly contribute to the overall local exoglycosidase activity.",
keywords = "Extracellular vesicle, Hexosaminidase, Rheumatoid arthritis, Synovial fibroblast, Transforming growth factor beta",
author = "M{\'a}ria P{\'a}szt{\'o}i and Barbara S{\'o}dar and Petra Misj{\'a}k and Krisztina P{\'a}l{\'o}czi and A. Kittel and K{\'a}lm{\'a}n T{\'o}th and K{\'a}roly Wellinger and P. G{\'e}her and Gy{\"o}rgy Nagy and Tam{\'a}s Lakatos and A. Falus and E. B{\'u}z{\'a}s",
year = "2013",
month = "1",
doi = "10.1016/j.imlet.2012.10.012",
language = "English",
volume = "149",
pages = "71--76",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - The recently identified hexosaminidase D enzyme substantially contributes to the elevated hexosaminidase activity in rheumatoid arthritis

AU - Pásztói, Mária

AU - Sódar, Barbara

AU - Misják, Petra

AU - Pálóczi, Krisztina

AU - Kittel, A.

AU - Tóth, Kálmán

AU - Wellinger, Károly

AU - Géher, P.

AU - Nagy, György

AU - Lakatos, Tamás

AU - Falus, A.

AU - Búzás, E.

PY - 2013/1

Y1 - 2013/1

N2 - Since the 1970s, numerous reports have described elevated hexosaminidase activities in rheumatoid arthritis. However, due to the overlapping substrate specificities of different hexosaminidases, identification of the exact enzyme(s) responsible for the elevated activity remains incomplete.In this work we tested if the recently described enzyme, hexosaminidase D was expressed in human arthritic joints, and could contribute to the elevated hexosaminidase activity in rheumatoid arthritis.Thermostable β-d-N-acetyl-galactosaminidase (hexosaminidase D) activities were determined in synovial fluid samples, synovial membranes, synovial fibroblast cell strains and synovial fibroblast-derived extracellular vesicles of patients with rheumatoid arthritis and osteoarthritis using chromogenic substrates. Expression of the HEXDC gene was detected both in steady state and in TGF-β treated synovial fibroblasts by real time PCR.Strikingly, hexosaminidase D accounted for approximately 50% of the total β-N-acetyl-galactosaminidase activity in synovial membranes and synovial fibroblasts, and it was responsible for the vast majority of the β-d-N-acetyl-galactosaminidase activity in synovial fluid samples. TGF-β downregulated the expression of hexosaminidase D in synovial fibroblasts dose-dependently. Of note, significant activity of hexosaminidase D was also found in association with extracellular vesicles released by synovial fibroblasts.This first study that describes the expression and disease relevance of the HEXDC gene in humans demonstrates the expression of this novel enzyme within the joints, and suggests that its activity may significantly contribute to the overall local exoglycosidase activity.

AB - Since the 1970s, numerous reports have described elevated hexosaminidase activities in rheumatoid arthritis. However, due to the overlapping substrate specificities of different hexosaminidases, identification of the exact enzyme(s) responsible for the elevated activity remains incomplete.In this work we tested if the recently described enzyme, hexosaminidase D was expressed in human arthritic joints, and could contribute to the elevated hexosaminidase activity in rheumatoid arthritis.Thermostable β-d-N-acetyl-galactosaminidase (hexosaminidase D) activities were determined in synovial fluid samples, synovial membranes, synovial fibroblast cell strains and synovial fibroblast-derived extracellular vesicles of patients with rheumatoid arthritis and osteoarthritis using chromogenic substrates. Expression of the HEXDC gene was detected both in steady state and in TGF-β treated synovial fibroblasts by real time PCR.Strikingly, hexosaminidase D accounted for approximately 50% of the total β-N-acetyl-galactosaminidase activity in synovial membranes and synovial fibroblasts, and it was responsible for the vast majority of the β-d-N-acetyl-galactosaminidase activity in synovial fluid samples. TGF-β downregulated the expression of hexosaminidase D in synovial fibroblasts dose-dependently. Of note, significant activity of hexosaminidase D was also found in association with extracellular vesicles released by synovial fibroblasts.This first study that describes the expression and disease relevance of the HEXDC gene in humans demonstrates the expression of this novel enzyme within the joints, and suggests that its activity may significantly contribute to the overall local exoglycosidase activity.

KW - Extracellular vesicle

KW - Hexosaminidase

KW - Rheumatoid arthritis

KW - Synovial fibroblast

KW - Transforming growth factor beta

UR - http://www.scopus.com/inward/record.url?scp=84872743597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872743597&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2012.10.012

DO - 10.1016/j.imlet.2012.10.012

M3 - Article

VL - 149

SP - 71

EP - 76

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 1-2

ER -